Position in ABBV
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$227,482
+$30,872 QoQ
Shares Held
904
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.62%
of 13F equity value
Holder Rank
#3,861
of 4,153 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Holos Integrated Wealth LLC holds $1,362,724 across 9 Drug Manufacturers - General names. ABBV ranks #2 (16.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
3,568 | $906,164 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
904 | $227,482 | |
| 3 | MRK |
Merck & Co., Inc.
|
951 | $122,203 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
353 | $44,598 | |
| 5 | AMGN |
Amgen Inc
|
113 | $40,919 | |
| 6 | PFE |
Pfizer Inc
|
672 | $16,181 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
49 | $2,823 | |
| 8 | GSK |
GSK plc
|
32 | $1,677 |
All Filings in ABBV
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $227,482 | 904 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $196,610 | 904 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $206,554 | 904 | Shares | Sole | 2026-01-05 | |
| 2025-09-30 | $192,409 | 831 | Shares | Sole | 2026-01-05 | |
| 2025-06-30 | $154,250 | 831 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $189,196 | 903 | Shares | Sole | 2025-08-08 | |
| 2024-12-31 | $160,463 | 903 | Shares | Sole | 2025-08-08 | |
| No filing history on record for this holder in this stock. | ||||||